|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/39 | |
| A61K 38/00 | |||
| C07K 14/78 | |||
| A61P 35/00 | |||
| A61K 39/395 | |||
| C07K 16/28 | |||
| A61K 45/06 |
| (11) | Number of the document | 2922566 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13856353.1 |
| Date of filing the European patent application | 2013-11-21 | |
| (97) | Date of publication of the European application | 2015-09-30 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/071267 |
| Date | 2013-11-21 |
| (87) | Number | WO 2014/081944 |
| Date | 2014-05-30 |
| (30) | Number | Date | Country code |
| 201261728906 P | 2012-11-21 | US | |
| 201261728914 P | 2012-11-21 | US | |
| 201261728912 P | 2012-11-21 | US | |
| 201361782550 P | 2013-03-14 | US | |
| 201361809541 P | 2013-04-08 | US |
| (72) |
ANDERSON, Mark, US
ATTAR, Ricardo, US
DIEM, Michael, US
HYUN, Linus, US
JACOBS, Steven, US
KING, Alastair, US
KLEIN, Donna, US
MOORES, Sheri, US
O`NEIL, Karyn, US
PICHA, Kristen, US
|
| (73) |
Janssen Biotech, Inc.,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (54) | EGFR AND C-MET-FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES |
| EGFR AND C-MET-FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES |